KEY FEATURES
| Full Name | Cyclin Dependent Kinase Inhibitor 2A |
|---|---|
| Synonym | P16; ARF; CDK4I; CMM2; INK4; INK4a; MLM; MTS1; TP16; P14; P14ARF; P16INK4a; P19; Melanoma P16; Cyclin-dependent kinase 4 inhibitor A; Multiple tumor suppressor 1 |
| Assay Type | Sandwich |
| Reactivity | Mouse |
| Range | 0.31-20ng/mL |
| Sensitivity | 0.13ng/mL |
| Sample Type | Serum,plasma and other biological fluids |
| Sample Volume | 100μL |
| Detection Wavelength | OD450 |
| Transportation Temperature | 2-8°C |
| Specificity | The kit detected Mouse CDKN2A in the samples and no significant cross-species reactions were found |
| Microplate | 96-wells plate breakable into 12 x 8 wells strip |
TEST PRINCIPLE
| This ELISA kit uses the Sandwich-ELISA principle. The micro ELISA plate provided in this kit has been pre-coated with an antibody specific to Mouse CDKN2A. Standards or samples are added to the micro ELISA plate wells and combined with the specific antibody. Then a biotinylated detection antibody specific for Mouse CDKN2A and Avidin-Horseradish Peroxidase (HRP) conjugate are added successively to each micro plate well and incubated. Free components are washed away. The substrate solution is added to each well. Only those wells that contain Mouse CDKN2A, biotinylated detection antibody and Avidin-HRP conjugate will appear blue in color. The enzyme-substrate reaction is terminated by the addition of stop solution and the color turns yellow. The optical density (OD) is measured spectrophotometrically at a wavelength of 450 nm ± 2 nm. The OD value is proportional to the concentration of Mouse CDKN2A. You can calculate the concentration of Mouse CDKN2A in the samples by comparing the OD of the samples to the standard curve. |
ELISA KIT COMPONENTS
Upon receipt, unpack promptly and store as recommended in the instructions.
| Components | Specifications | Storage and Notes |
|---|---|---|
| Micro Plate | 96T: 8 wells×12 strips 48T: 8 wells×6 strips | Unopened: -20°C, 12 months Unused: Put it back in the aluminum foil bag and seal it, store it at -20°C. |
| Reference Standard | 96T: 2 vials 48T: 1 vial | Unopened: -20°C, 12 months Please use freshly dissolved standards for each experiment. Discard any unused standards after dissolution. |
| Biotinylated Detection Ab Concentrate (100×) | 96T: 120μL×1 vial 48T: 60μL×1 vial | Unopened: -20°C, 12 months Unused: Please seal the concentrate and store it at -20°C, and discard the working solution. |
| HRP Conjugate Concentrate (100×) | 96T: 120μL×1 vial 48T: 60μL×1 vial | Unopened: -20°C(Protect from light), 12 months Unused: Please seal the concentrate and store it at -20°C, and discard the working solution. |
| Biotinylated Detection Ab Diluent | 14mL×1 | 2-8℃, 12 months |
| HRP Conjugate Diluent | 14mL×1 | 2-8℃, 12 months |
| Reference Standard & Sample Diluent | 20mL×1 | 2-8℃, 12 months |
| Washing Buffer Concentrate (25×) | 30mL×1 | 2-8℃, 12 months |
| Substrate Reagent(TMB) | 10mL×1 | 2-8°C(Protect from light),12 months |
| Stop Solution | 7mL×1 | 2-8°C/Room temperature |
ASSAY PROCEDURES

TYPICAL DATA

Mouse CDKN2A ELISA Standard Curve
Typical data are for reference only and curves should be replotted for each experiment. The Logistics function is recommended for fitting.
PRECISION
Intra-Assay Precision (Precision within an assay): Three samples of known concentration were tested twenty times on one plate to assess intra-assay precision.
Inter-Assay Precision (Precision between assays): Three samples of known concentration were tested in twenty separate assays to assess inter-assay precision. Assays were performed by at least three technicians using two lots of components.
| Intra-assay Precision | Inter-assay Precision | |||||
|---|---|---|---|---|---|---|
| Sample | 1 | 2 | 3 | 1 | 2 | 3 |
| n | 20 | 20 | 20 | 20 | 20 | 20 |
| Mean (ng/mL) | 1.11 | 1.88 | 6.73 | 1.11 | 1.93 | 6.12 |
| Standard deviation | 0.06 | 0.08 | 0.34 | 0.07 | 0.09 | 0.23 |
| CV(%) | 5.4 | 4.51 | 4.99 | 6.49 | 4.65 | 3.82 |
RECOVERY
The recovery of Mouse CDKN2A spiked to three different levels in samples throughout the range of the assay in various matrices was evaluated.
| Sample Type | Range (%) | Average Recovery (%) |
|---|---|---|
| Serum(n=8) | 86-97 | 92 |
| EDTA plasma (n=8) | 92-106 | 99 |
| Cell culture media (n=8) | 89-104 | 95 |
LINEARITY
To assess the linearity of the assay, samples containing and/or spiked with high concentrations of Mouse CDKN2A in various matrices were diluted with the Reference Standard & Sample Diluent to produce samples with values within the dynamic range of the assay.

Products associated with P16 ELISA Kits
| CDK4 ELISA Kit | publications with P16 and CDK4 |
| CCND1 ELISA Kit | publications with P16 and CCND1 |
| TP53 ELISA Kit | publications with P16 and TP53 |
| MDM2 ELISA Kit | publications with P16 and MDM2 |
| CDK6 ELISA Kit | publications with P16 and CDK6 |
| NPM1 ELISA Kit | publications with P16 and NPM1 |
Pathways associated with P16 ELISA Kit
| Apoptosis Pathway | Apoptosis Pathway |
| Apoptosis Modulation And Signaling Pathway | Apoptosis Modulation And Signaling Pathway |
| Bladder Cancer Pathway | Bladder Cancer Pathway |
| Cell Cycle Pathway | Cell Cycle Pathway |
| Cell Cycle, Mitotic Pathway | Cell Cycle, Mitotic Pathway |
| Cellular Senescence Pathway | Cellular Senescence Pathway |
Diseases associated with P16 ELISA Kit
| Neoplasms | publications with P16 and Neoplasms |
| Adenocarcinoma | publications with P16 and Adenocarcinoma |
| Urogenital Neoplasms | publications with P16 and Urogenital Neoplasms |
| Cell Transformation, Neoplastic | publications with P16 and Cell Transformation, Neoplastic |
| Lymphoma | publications with P16 and Lymphoma |
| Lung Neoplasms | publications with P16 and Lung Neoplasms |
| Neoplasms, Experimental | publications with P16 and Neoplasms, Experimental |
| Nervous System Diseases | publications with P16 and Nervous System Diseases |
| Glioma | publications with P16 and Glioma |
| Pancreatic Neoplasms | publications with P16 and Pancreatic Neoplasms |
Organs/Tissues associated with P16 ELISA Kit
| Blood | publications with P16 and Blood |
| Skin | publications with P16 and Skin |
| Lung | publications with P16 and Lung |
| Brain | publications with P16 and Brain |
| Liver | publications with P16 and Liver |
| Bone | publications with P16 and Bone |
| Lymph Node | publications with P16 and Lymph Node |
| Lymph | publications with P16 and Lymph |
| Stomach | publications with P16 and Stomach |
| Cervix | publications with P16 and Cervix |